Show Summary Details
Page of

Neuropeptides in OCD 

Neuropeptides in OCD
Chapter:
Neuropeptides in OCD
Author(s):

Anahid Kabasakalian

, and Eric Hollander

DOI:
10.1093/med/9780190228163.003.0026
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 June 2022

The chapter considers past investigations of neuropeptides and their dysregulation in obsessive-compulsive disorder (OCD) and related conditions, and future directions for study. It reviews how the diagnostic reclassification of OCD in DSM-5, the stress response, reward mechanisms, as well as neuropsychological, functional imaging and genetic studies contribute to understanding of the role that neuropeptides have played in OCD and related areas. Avenues of further investigation are considered in the context of novel endogenous neuropeptides, newly identified roles for established neuropeptides, and the greater understanding of interactions between neuropeptides both with other neuropeptides and with neurotransmitters.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.